Richard ShervaOrapan SripichaiKenneth AbelQianli MaJohanna WhitacreVach AngkachatchaiWattanan MakarasaraPranee WinichagoonSaovaros SvastiSuthat FucharoenAndreas BraunLindsay A. FarrerBoston University School of MedicineBoston UniversityMahidol UniversitySequenom Inc.Human BioMolecular Research InstituteIllumina, Inc.Innovive, Inc2018-09-242018-09-242010-03-30BMC Medical Genetics. Vol.11, No.1 (2010)147123502-s2.0-77950445745https://repository.li.mahidol.ac.th/handle/20.500.14594/28751Background: Patients with Hb E/β0 thalassemia display remarkable variability in disease severity. To identify genetic modifiers influencing disease severity, we conducted a two-stage genome scan in groups of 207 mild and 305 severe unrelated patients from Thailand with Hb E/β0 thalassemia and normal α-globin genes.Methods: First, we estimated and compared the allele frequencies of approximately 110,000 gene-based single nucleotide polymorphisms (SNPs) in pooled DNAs from different severity groups. The 756 SNPs that showed reproducible allelic differences at P < 0.02 by pooling were selected for individual genotyping.Results: After adjustment for age, gender and geographic region, logistic regression models showed 50 SNPs significantly associated with disease severity (P < 0.05) after Bonferroni adjustment for multiple testing. Forty-one SNPs in a large LD block within the β-globin gene cluster had major alleles associated with severe disease. The most significant was bthal_bg200 (odds ratio (OR) = 5.56, P = 2.6 × 10-13). Seven SNPs in two distinct LD blocks within a region centromeric to the β-globin gene cluster that contains many olfactory receptor genes were also associated with disease severity; rs3886223 had the strongest association (OR = 3.03, P = 3.7 × 10-11). Several previously unreported SNPs were also significantly associated with disease severity.Conclusions: These results suggest that there may be an additional regulatory region centromeric to the β-globin gene cluster that affects disease severity by modulating fetal hemoglobin expression. © 2010 Sherva et al; licensee BioMed Central Ltd.Mahidol UniversityBiochemistry, Genetics and Molecular BiologyMedicineArticleSCOPUS10.1186/1471-2350-11-51